A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
Winston CaiAndrew CaganZeling HeAshwin N AnanthakrishnanPublished in: Digestive diseases and sciences (2020)
Surrogate markers suggesting possible irreversible bowel damage and active disease demonstrate the greatest influence on IBD-related healthcare costs.